Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Ardelyx reported $63.06M in Current Liabilities for its fiscal quarter ending in March of 2023.

Current Liabilities Change
Abbott ABT:US USD 14.53B 959M
Amgen AMGN:US USD 14.22B 1.47B
Ardelyx ARDX:US USD 63.06M 2.54M
Chimerix CMRX:US USD 16.43M 3.98M
Corcept Therapeutics CORT:US USD 78.86M 6.37M
Curis CRIS:US USD 8.07M 1.94M
Life Technologies LIFE:US USD 13.65M 208K
TG Therapeutics TGTX:US USD 63.08M 9.88M
United Therapeutics UTHR:US USD 324.6M 18.6M